Reciprocal regulation of C-Maf tyrosine phosphorylation by Tec and Ptpn22

PLoS One. 2015 May 20;10(5):e0127617. doi: 10.1371/journal.pone.0127617. eCollection 2015.

Abstract

C-Maf plays an important role in regulating cytokine production in TH cells. Its transactivation of IL-4 is optimized by phosphorylation at Tyr21, Tyr92, and Tyr131. However, the molecular mechanism regulating its tyrosine phosphorylation remains unknown. In this study, we demonstrate that Tec kinase family member Tec, but not Rlk or Itk, is a tyrosine kinase of c-Maf and that Tec enhances c-Maf-dependent IL-4 promoter activity. This effect of Tec is counteracted by Ptpn22, which physically interacts with and facilitates tyrosine dephosphorylation of c-Maf thereby attenuating its transcriptional activity. We further show that phosphorylation of Tyr21/92/131 of c-Maf is also critical for its recruitment to the IL-21 promoter and optimal production of this cytokine by TH17 cells. Thus, manipulating tyrosine phosphorylation of c-Maf through its kinases and phosphatases can have significant impact on TH cell-mediated immune responses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cell Nucleus / metabolism
  • HEK293 Cells
  • Humans
  • Interleukin-4 / genetics
  • Interleukins / biosynthesis
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Phosphorylation
  • Phosphotyrosine / metabolism*
  • Promoter Regions, Genetic / genetics
  • Protein Binding
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22 / metabolism*
  • Protein-Tyrosine Kinases / metabolism*
  • Proto-Oncogene Proteins c-maf / metabolism*
  • Th17 Cells / metabolism
  • Transcriptional Activation / genetics
  • Two-Hybrid System Techniques

Substances

  • Interleukins
  • Proto-Oncogene Proteins c-maf
  • Interleukin-4
  • Phosphotyrosine
  • Tec protein-tyrosine kinase
  • Protein-Tyrosine Kinases
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22
  • Ptpn22 protein, mouse
  • interleukin-21

Grants and funding

This work is supported by grants from Ministry of Science and Technology (MOST 103-2320-B-002 -035), National Health Research Institutes (NHRI-EX100-9941SI) and Excellent translational Medicine Research of NTUCM and NTUH to SCM. Additional funding comes from an award (W81XWH-11-1-0492) from the Department of Defense, USA to ICH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ministry of Science and Technology: http://www.most.gov.tw/. National Health Research Institutes: http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do.